Dutasteride Reduces Prostatitis Symptoms Compared With Placebo in Men Enrolled in the REDUCE Study
Abstract
Purpose:
Men at risk for prostate cancer may concurrently experience chronic prostatitis or pelvic pain. We evaluated the effect of dutasteride on prostatitis-like symptoms in the REDUCE study population.
Materials and Methods:
REDUCE was a 4-year, randomized, double-blind, placebo controlled study of prostate cancer risk reduction with 0.5 mg dutasteride vs placebo in men 50 to 75 years old with prostate specific antigen 2.5 to 10 ng/ml and a negative prostate biopsy in the previous 6 months. In this analysis we investigated change from baseline in Chronic Prostatitis Symptom Index in men with prostatitis-like pain (Chronic Prostatitis Symptom Index pain subscore 5 or greater) and prostatitis-like syndrome (perineal or ejaculatory pain plus Chronic Prostatitis Symptom Index pain subscore 4 or greater), the proportion of subjects with at least a moderate Chronic Prostatitis Symptom Index response (6-unit or greater improvement) and reports of new onset clinical prostatitis.
Results:
Of 5,379 men with a total baseline Chronic Prostatitis Symptom Index score 678 (12.6%) had prostatitis-like pain and 427 (7.9%) had prostatitis-like syndrome. Chronic Prostatitis Symptom Index total score decreased significantly at 48 months in the dutasteride group vs placebo in men with prostatitis-like pain (p <0.0001) and with prostatitis-like syndrome (t test p = 0.03). There were significantly more Chronic Prostatitis Symptom Index responders with dutasteride vs placebo in the prostatitis-like pain (49% vs 37%, respectively, p = 0.0033) and prostatitis-like syndrome (46% vs 35%, Fisher's exact test p = 0.0265) subgroups. Prostatitis was reported as an adverse event by significantly more men randomized to placebo (3.6%) than to dutasteride (2.5%, p = 0.003).
Conclusions:
Long-term dutasteride therapy resulted in improvement in prostatitis related symptoms in older men with an increased prostate specific antigen.
References
- 1 : Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol2004; 172: 839. Link, Google Scholar
- 2 : Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology2009; 73: 538. Google Scholar
- 3 : Clinical practice: Chronic prostatitis and the chronic pelvic pain syndrome . N Engl J Med2006; 355: 1690. Google Scholar
- 4 :
Treatment of chronic prostatitis/chronic pelvic pain syndrome . In: Evidence-Based Urology. Edited by . Chichester, UK: Wiley-Blackwell2010: 111. Google Scholar - 5 : Role of alpha1-blockers in chronic prostatitis syndromes. BJU Int2008; 101: 11. Google Scholar
- 6 : Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med2004; 141: 581. Google Scholar
- 7 : Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med2008; 359: 2663. Google Scholar
- 8 : The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol2010; 57: 123. Google Scholar
- 9 : Effect of dutasteride on the risk of prostate cancer. N Engl J Med2010; 362: 1192. Google Scholar
- 10 :
5-α-Reductase therapy for chronic prostatitis . In: Textbook of Prostatitis. Oxford, UK: ISIS Medical Media1999: 333. Google Scholar - 11 : Chronic prostatic pain: A new treatment option with finasteride? . Scand J Urol Nephrol1997; 31: 213. Google Scholar
- 12 : Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study. Urology1999; 53: 502. Google Scholar
- 13 : Chemoprevention of prostate cancer in men at high risk: rationale and design of the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial. J Urol2004; 172: 1314. Link, Google Scholar
- 14 : Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology1998; 51: 578. Google Scholar
- 15 : Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment. Drugs Aging2003; 20: 1111. Google Scholar
- 16 : Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial. J Urol2007; 178: 896. Link, Google Scholar
- 17 : The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure: Chronic Prostatitis Collaborative Research Network . J Urol1999; 162: 369. Link, Google Scholar
- 18 : Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res2006; 15: 299. Google Scholar
- 19 : Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med2010; 170: 1586. Google Scholar
- 20 : Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol2001; 165: 842. Link, Google Scholar
- 21 : Prevalence of prostatitis-like symptoms in a managed care population. J Urol2006; 176: 593. Link, Google Scholar
- 22 : The association of abuse and symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome: results from the Boston Area Community Health survey. J Gen Intern Med2007; 22: 1532. Google Scholar
- 23 : Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. J Urol2004; 172: 542. Link, Google Scholar
- 24 : A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int2004; 93: 991. Google Scholar
- 25 :
The role of the animal model in the study of prostatitis . In: Infectiology: Urinary Tract Infections. Edited by . Basel, Switzerland: S Karger AG1997: 89. Google Scholar - 26 : Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. Br J Urol1982; 54: 729. Google Scholar
- 27 : Etiology of voiding dysfunction in men less than 50 years of age. Urology1996; 47: 836. Google Scholar
- 28 : The chronic prostatitis-chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements. J Urol2002; 167: 137. Link, Google Scholar
- 29 : A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol2004; 171: 284. Link, Google Scholar
- 30 : The influence of finasteride on the development of prostate cancer. N Engl J Med2003; 349: 215. Google Scholar
